Bengaluru, November 19, 2026: The Centre for Cellular and Molecular Platforms (C-CAMP), in partnership with Imperial College London, welcomed Indegene as the first industry partner of the Indo-UK Life Science Corridor.
Supported through the Imperial Global India initiative, the Corridor connects world-class research in India and the UK with entrepreneurship, industry expertise, and pathways to translation. It is designed to enable formal, two-way sharing of knowledge and evidence on priority challenges, innovation readiness, and ecosystem needs. Indegene, C-CAMP, and Imperial College London will co-develop entrepreneurship programs and support the exchange of knowledge and talent between the two countries.
Indegene is the AI-native operating partner for modern life sciences, bringing deep industry context to the Corridor, and a track record of working with the world’s top 20 biopharma companies.
As part of the collaboration, Indegene will help define industry challenges and support startup exchanges and ecosystem immersion programs. Initial focus areas include antimicrobial resistance, diagnostics, digital health, agritech, brain science, and mental health.
The three organizations made the announcement at the C-CAMP–Imperial joint Roundtable on International Partnerships for AI Discovery and Innovation, convened under the Government of Karnataka’s Global Innovation Alliance initiative as part of the Bengaluru Tech Summit 2026.
“Global health challenges cannot be solved in isolation”, said Dr. Taslimarif Saiyed, CEO, C-CAMP. “This understanding was central to our vision for the Indo-UK Life Science Corridor, which connects the complementary innovation ecosystems of Imperial College London and C-CAMP to enable cross-border problem-solving. Exposure to both ecosystems will produce smarter, more scalable, and more accessible innovations relevant to both populations.”
Amanda Wolthuizen, Vice-President (Strategy), Imperial College London, said: "Welcoming Indegene as the first industry partner of the Indo-UK Life Sciences Innovation Corridor is an important moment for this partnership. When we launched the initiative with C-CAMP earlier this year, we wanted to create a platform where research, talent and industry could come together to accelerate new technologies and solve shared global challenges. Indegene's expertise in life sciences make them an ideal first partner as we strengthen India-UK links and grow our network of industry collaborators.”
Dr. Saurabh Jain, Vice President - Global Delivery Centers, CSR, and Advocacy, Indegene, said, “The next decade of life sciences innovation will be defined by how well we connect science, talent, and industry across borders. This Corridor brings together the strengths of India and the UK, giving promising ideas a clearer path from discovery to real-world impact. The partnership reflects our continued commitment to support deep science, strengthen translation pathways, and help promising innovation reach scale.”
For over a decade, C-CAMP has been a cornerstone of innovation, funding, incubating, and helping advance more than 700 startups. These startups have raised more than $720 million and have a cumulative valuation of approximately $2.7 billion.
C-CAMP has enabled the completion of more than 6,000 research projects and trained over 2,200 scientific personnel. More than 420 life sciences products are in the market, 1,000 patents have been filed by C-CAMP startups, and over 300 publications have been supported. These technologies have touched more than 70 million lives.
Imperial College London launched Imperial Global India in 2025 to drive high-impact science and technology programs with academic, industrial, and innovation partners, nurture a two-way flow of STEMB talent between the UK and India, and support Imperial’s growing Indian alumni network.
Indegene Limited (BSE: 544172, NSE: INDGN) is the strategic operating partner to the life sciences industry, orchestrating commercial, medical, R&D, and safety operations across the product lifecycle. Trusted by the world’s top 20 biopharma companies, Indegene helps run complex, highly regulated workflows at global scale.
Indegene combines deep life sciences expertise with AI-embedded platforms and governed operating models to improve speed, consistency, and compliance across mission-critical operations. By integrating technology into how work is executed and scaled, it enables life sciences organizations to deliver measurable outcomes in regulated environments. For more information, visit www.indegene.com.
C-CAMP: cdebarshini@ccamp.res.in | Imperial College London: s.johns@imperial.ac.uk | Indegene: yadunandan.kv@indegene.com